Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

293031323334353637

LONDON BRIEFING: Haleon reports double-digit revenue growth

20th Sep 2022 07:51

(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More

LONDON MARKET OPEN: Recession and inflation fears dominate attention

16th Sep 2022 08:43

(Alliance News) - The mood remained downbeat at the end of a sour week for global equities, after data dashed hopes that US inflation is easing fast enough to warrant less aggressive interest rate hikes by the Federal Reserve. Read More

TOP NEWS: Two AstraZeneca drugs get recommendations for EU approval

16th Sep 2022 08:16

(Alliance News) - AstraZeneca PLC on Friday said it received two recommendations for drug approvals in the EU, while a drug for blood disorder paroxysmal nocturnal haemoglobinuria met its primary endpoint in a phase three trial. Read More

LONDON BRIEFING: UK retail sales fall much steeper than expected

16th Sep 2022 07:49

(Alliance News) - Stocks in London are set to end a difficult week on a downbeat note after economic data raised the prospect of the Federal Reserve acting even more aggressively to tame inflation. Read More

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday: Read More

CORRECT: AstraZeneca shares further information on oncology trial data

14th Sep 2022 14:43

(Clarifying details of Poseidon trial.) Read More

AstraZeneca shares further Imfinzi, Tagrisso, Enhertu trial data

12th Sep 2022 08:44

(Alliance News) - AstraZenea PLC on Monday shared several positive developments for its oncology pipeline, which will be presented at the European Society for Medical Oncology Congress 2022 in Paris. Read More

AstraZeneca, Merck's Lynparza shows survival benefit in ovarian cancer

9th Sep 2022 14:31

(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Friday said their cancer drug lynparza, or olaparib, showed positive overall survival data for patients with ovarian cancer in three phase III studies. Read More

LONDON BROKER RATINGS: UBS raises Admiral; Morgan Stanley cuts Astra

7th Sep 2022 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon: Read More

UK dividends calendar - next 7 days

5th Sep 2022 15:50

Read More

AstraZeneca gets approval for two treatments in US and China

5th Sep 2022 08:51

(Alliance News) - AstraZeneca PLC on Monday said it received two treatment approvals in the US and in China respectively. Read More

LONDON MARKET BRIEFING: Gazprom's move gets week off to bumpy start

5th Sep 2022 07:51

(Alliance News) - Stocks in London are set to kick off the new week on the back foot, as Russia's move to stop gas deliveries to Europe is giving investors pause, amid growing fears of an energy crisis. Read More

AstraZeneca says Evusheld Covid-19 treatment approved in Japan

30th Aug 2022 14:10

(Alliance News) - AstraZeneca PLC on Tuesday said its Evusheld Covid-19 treatment was approved in Japan for prevention and treatment of symptomatic disease caused by SARS-CoV-2 infection. Read More

AstraZeneca says data shows Farxiga reduces cardiovascular death risk

29th Aug 2022 19:16

(Alliance News) - AstraZeneca PLC on Saturday said new data show its Farxiga "significantly" lowers the risk of cardiovascular death in patients with heart failure. Read More

CORRECT: Japan approves Astra's Lynparza, Tagrisso, and Ultomiris

26th Aug 2022 06:03

(Correcting the phase of the OlympiA trial.) Read More

TOP NEWS: Japan approves Astra's Lynparza, Tagrisso, and Ultomiris

25th Aug 2022 08:57

(Alliance News) - AstraZeneca PLC on Thursday shared its latest regulatory successes in a key market, winning approvals for three treatments in Japan. Read More

TOP NEWS: AstraZeneca to present cancer drug data at oncology congress

24th Aug 2022 08:00

(Alliance News) - AstraZeneca PLC on Wednesday announced it will provide new safety and efficacy data on several of its cancer drugs, purporting to show longer survival for cancer patients. Read More

IN BRIEF: Aptamer's annual revenue doubles on new contract wins

22nd Aug 2022 11:04

Aptamer Group PLC - York, England-based provider of custom services, diagnostics and therapeutics for biotechnology and pharmaceutical firms - For the year ended June 30, revenue is expected to more than double to GBP4.0 million from GBP1.6 million reported the prior 15-month period. Read More

LONDON MARKET CLOSE: FTSE 100 keeps head above water as pound sinks

19th Aug 2022 17:07

(Alliance News) - The FTSE 100 managed to outperform European counterparts on Friday due to weakness in the pound as consumer confidence in the UK fell to a record low, while attention turns to next week's Jackson Hole Symposium. Read More

LONDON MARKET MIDDAY: Weaker pound unable to keep FTSE in green

19th Aug 2022 12:06

(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade. Read More

293031323334353637
FTSE 100 Latest
Value8,774.65
Change-17.15